Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. (DNA) has a 18-report earnings history dating back to Nov 15, 2021. Its average absolute post-earnings move is ±11.58%, and 38.9% of those reactions were positive. Its largest post-earnings gain was +22.73% (Mar 28, 2022) and its largest decline was -30.48% (Feb 26, 2026). The next earnings report is predicted for 2026-08-12 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
18
Avg Abs. Movement
±11.58%
Positive %
38.9%
Negative %
61.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☽ POST | $10.12 | $10.63 | $10.37 | 88,060 | -13.89% | open_in_new |
| Feb 26, 2026 | ☽ POST | $9.35 | $9.72 | $9.71 | 979,200 | -30.48% | open_in_new |
| Nov 06, 2025 | ☽ POST | $11.60 | $11.60 | $11.30 | 1,260,900 | -20.8% | open_in_new |
| Aug 07, 2025 | ☽ POST | $14.09 | $14.28 | $13.46 | 1,512,200 | -8.69% | open_in_new |
| May 06, 2025 | ☽ POST | $6.75 | $6.93 | $6.45 | 1,079,800 | +14.73% | open_in_new |
| Feb 25, 2025 | ☽ POST | $10.40 | $10.56 | $10.29 | 2,878,700 | -11.47% | open_in_new |
| Nov 12, 2024 | ☽ POST | $8.52 | $8.78 | $8.39 | 1,485,800 | +2.5% | open_in_new |
| May 09, 2024 | ☽ POST | $36.40 | $38.52 | $36.80 | 1,514,100 | -17.28% | open_in_new |
| Feb 29, 2024 | ☽ POST | $61.60 | $64.40 | $60.80 | 892,085 | -15.13% | open_in_new |
| Nov 08, 2023 | ☽ POST | $62.40 | $63.20 | $59.60 | 626,703 | -15.44% | open_in_new |
| Aug 09, 2023 | ☽ POST | $82.80 | $87.20 | $80.40 | 486,650 | -12.94% | open_in_new |
| May 10, 2023 | ☽ POST | $55.60 | $57.20 | $54.00 | 687,110 | -1.48% | open_in_new |
| Mar 01, 2023 | ☽ POST | $58.00 | $59.20 | $56.00 | 687,923 | +0% | open_in_new |
| Nov 14, 2022 | ☽ POST | $113.20 | $114.40 | $107.20 | 642,170 | -0.37% | open_in_new |
| Aug 15, 2022 | ☽ POST | $149.60 | $154.20 | $139.60 | 1,093,255 | +7.16% | open_in_new |
| May 16, 2022 | ☽ POST | $106.00 | $108.80 | $97.20 | 548,395 | +12.76% | open_in_new |
| Mar 28, 2022 | ☽ POST | $148.00 | $155.48 | $149.60 | 687,768 | +22.73% | open_in_new |
| Nov 15, 2021 | ☀ PRE | $518.00 | $530.00 | $518.80 | 151,543 | +0.54% | open_in_new |
Earnings Count
18
Total earnings in dataset
Avg Abs. Movement
±11.58%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260610 | open_in_new SEC.gov |
| 4 | 20260526 | open_in_new SEC.gov |
| 144 | 20260522 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 144 | 20260513 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
| 8-K | 20260507 | open_in_new SEC.gov |
| ARS | 20260429 | open_in_new SEC.gov |
| DEFA14A | 20260429 | open_in_new SEC.gov |
| DEF 14A | 20260429 | open_in_new SEC.gov |
Frequently asked about DNA earnings
When does Ginkgo Bioworks Holdings, Inc. report earnings next? expand_more
Ginkgo Bioworks Holdings, Inc. (DNA)'s next earnings date is approximate for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DNA stock move after earnings? expand_more
Over 18 reports, DNA has moved an average of ±11.58% the session after earnings, closing higher 38.9% of the time.
What was DNA's biggest post-earnings move? expand_more
DNA's largest post-earnings gain on record was +22.73% on Mar 28, 2022, and its largest decline was -30.48% on Feb 26, 2026.
Where can I find Ginkgo Bioworks Holdings, Inc.'s SEC filings? expand_more
All of Ginkgo Bioworks Holdings, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right